MDT

83.29

0.11% 0.09

Vorhandelsmarkt: 83.30 0.010 +0.01%

Medtronic Plc (MDT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$83.20

Offen:

$82.98

24-Stunden-Volumen:

7.11M

Relative Volume:

0.71

Marktkapitalisierung:

$106.61B

Einnahmen:

$36.36B

Nettoeinkommen (Verlust:

$4.84B

KGV:

22.35

EPS:

3.7261

Netto-Cashflow:

$5.43B

1W Leistung:

-0.34%

1M Leistung:

+4.98%

6M Leistung:

-15.53%

1J Leistung:

-7.05%

1-Tages-Spanne:

$82.80

$84.03

1-Wochen-Bereich:

$78.97

$84.79

52-Wochen-Spanne:

$73.31

$106.33

Medtronic Plc Stock (MDT) Company Profile

Firmenname

Medtronic Plc

Sektor

Healthcare (1089)

Branche

Medical Devices (141)

Telefon

01135314381700

Adresse

BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY

Mitarbeiter

95,000

Twitter

@Medtronic

Nächster Verdiensttermin

2026-08-18

Neueste SEC-Einreichungen

MDT's Discussions on Twitter

Compare MDT vs ABT, SYK, BSX, EW

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MDT Medtronic Plc	83.29	106.61B	36.36B	4.84B	5.43B	3.7261
ABT Abbott Laboratories	101.66	177.07B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	319.14	122.35B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	43.77	65.06B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	85.00	48.94B	6.30B	1.07B	1.09B	1.8406

Medtronic Plc Stock (MDT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-02-13	Fortgesetzt	Barclays	Overweight
2026-02-09	Hochstufung	Needham	Hold → Buy
2026-02-03	Fortgesetzt	Citigroup	Buy
2026-01-30	Fortgesetzt	Wells Fargo	Overweight
2026-01-06	Hochstufung	William Blair	Mkt Perform → Outperform
2025-11-19	Hochstufung	Goldman	Sell → Neutral
2025-06-30	Hochstufung	Wolfe Research	Underperform → Peer Perform
2025-06-16	Eingeleitet	Leerink Partners	Outperform
2025-03-04	Hochstufung	Citigroup	Neutral → Buy
2024-10-10	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2024-08-21	Bestätigt	Oppenheimer	Perform
2024-08-15	Hochstufung	UBS	Sell → Neutral
2024-08-14	Herabstufung	Stifel	Buy → Hold
2024-05-30	Eingeleitet	Goldman	Sell
2023-07-19	Eingeleitet	Robert W. Baird	Neutral
2023-06-30	Eingeleitet	CL King	Buy
2023-05-30	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2023-04-24	Hochstufung	Wells Fargo	Equal Weight → Overweight
2023-03-29	Herabstufung	UBS	Buy → Sell
2023-01-09	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2022-11-23	Herabstufung	Citigroup	Buy → Neutral
2022-11-23	Herabstufung	Oppenheimer	Outperform → Perform
2022-11-16	Herabstufung	Deutsche Bank	Buy → Hold
2022-10-18	Eingeleitet	Barclays	Equal Weight
2022-10-13	Eingeleitet	Mizuho	Buy
2022-10-12	Eingeleitet	Jefferies	Hold
2022-08-24	Herabstufung	Raymond James	Outperform → Mkt Perform
2022-07-06	Eingeleitet	Wolfe Research	Underperform
2022-06-01	Herabstufung	Atlantic Equities	Overweight → Neutral
2022-05-27	Herabstufung	Needham	Buy → Hold
2022-04-13	Herabstufung	Truist	Buy → Hold
2022-03-02	Fortgesetzt	BofA Securities	Buy
2022-01-10	Herabstufung	BTIG Research	Buy → Neutral
2022-01-07	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-01-04	Herabstufung	Piper Sandler	Overweight → Neutral
2021-12-17	Herabstufung	JP Morgan	Overweight → Neutral
2021-12-16	Herabstufung	Wells Fargo	Overweight → Equal Weight
2021-12-10	Eingeleitet	RBC Capital Mkts	Outperform
2021-06-10	Fortgesetzt	Cowen	Outperform
2021-05-25	Eingeleitet	Barclays	Equal Weight
2021-04-15	Eingeleitet	Atlantic Equities	Overweight
2020-12-15	Hochstufung	Goldman	Sell → Neutral
2020-12-15	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-10-08	Hochstufung	Bernstein	Mkt Perform → Outperform
2020-10-08	Hochstufung	Stifel	Hold → Buy
2020-09-11	Eingeleitet	Wolfe Research	Peer Perform
2020-05-14	Herabstufung	DZ Bank	Buy → Hold
2020-03-30	Herabstufung	Needham	Strong Buy → Buy
2020-03-25	Hochstufung	DZ Bank	Hold → Buy
2020-03-05	Eingeleitet	Citigroup	Buy
2020-02-13	Eingeleitet	Goldman	Sell
2020-01-08	Eingeleitet	SunTrust	Buy
2020-01-02	Hochstufung	Guggenheim	Neutral → Buy
2019-06-05	Hochstufung	Wells Fargo	Market Perform → Outperform
2019-02-04	Bestätigt	Needham	Strong Buy
2019-01-03	Eingeleitet	Deutsche Bank	Buy
2019-01-02	Herabstufung	Citigroup	Buy → Neutral
2018-12-19	Hochstufung	JP Morgan	Neutral → Overweight
2018-11-28	Eingeleitet	UBS	Buy
2018-10-16	Eingeleitet	Barclays	Overweight
2018-08-27	Bestätigt	Argus	Buy

Alle ansehen

Medtronic Plc Aktie (MDT) Neueste Nachrichten

Jul 20, 2026

Medtronic (MDT) to Announce Q1 FY2027 Earnings on August 18 - GuruFocus

Jul 20, 2026

Medtronic to announce financial results for its first quarter of fiscal year 2027 - Investing News Network

Jul 20, 2026

Medtronic to report Q1 FY2027 financial results on September 1, 2026 - Pluang

Jul 20, 2026

Urology Devices Market Size to Reach USD 80.0 Billion by 2035 | SNS Insider - GlobeNewswire Inc.

Jul 20, 2026

Medtronic sets Sept. 1 date for its next financial report - Stock Titan

Jul 20, 2026

Medtech acquisitions: DePuy Synthes, Medtronic add to portfolios - Today's Medical Developments

Jul 20, 2026

Jul 19, 2026

Medtronic stock holds steady as diabetes and cardiovascular growth underpin recent earnings - ad-hoc-news.de

Jul 19, 2026

Jul 18, 2026

Medtronic acquires SPR Therapeutics for USD 650 million - Medical Buyer

Jul 18, 2026

Jul 17, 2026

Medtronic : and Apollo Hospitals Announce Strategic Partnership to Establish State-of-the-Art Advanced ICU in Hyderabad - marketscreener.com

Jul 17, 2026

Medtronic completes SPR Therapeutics acquisition - MedTech Dive

Jul 17, 2026

Medtronic (MDT) Completes SPR Therapeutics Deal To Expand Non Opioid Pain Care - Yahoo Finance

Jul 17, 2026

Medtronic stock trades steadily as diabetes and cardiovascular businesses support earnings - ad-hoc-news.de

Jul 17, 2026

Medtronic and Apollo Hospitals Announce Strategic Partnership to Establish State-of-the-Art Advanced ICU in Hyderabad - Big News Network.com

Jul 17, 2026

Jul 16, 2026

Medtronic completes $650M acquisition of SPR Therapeutics - Investing.com UK

Jul 16, 2026

Medtronic And Apollo Hospitals Announce Strategic Partnership To Establish State-Of-The-Art Advanced ICU In Hyderabad. - TRIPURA STAR NEWS

Jul 16, 2026

Medtronic Completes $650 Million Acquisition of SPR Therapeutics - marketscreener.com

Jul 16, 2026

Medtronic completes $650M acquisition of SPR Therapeutics By Investing.com - Investing.com Canada

Jul 16, 2026

Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain - Medtronic

Jul 16, 2026

Medtronic Adds 60-Day Pain Therapy Without Permanent Implant - Stock Titan

Jul 16, 2026

Medtronic (MDT) Completes SPR Therapeutics Acquisition To Expand Non Opioid Pain Care - Sahm

Jul 16, 2026

Jul 15, 2026

Medtronic plc completed the acquisition of SPR Therapeutics, Inc. - marketscreener.com

Jul 15, 2026

Medtronic faces first trial in US hernia mesh injury cases - Reuters

Jul 15, 2026

Medtronic PLC (NYSE:MDT): A Top Dividend Stock for Quality and Income Investors - ChartMill

Jul 15, 2026

Jul 14, 2026

Medtronic PLC stock underperforms Tuesday when compared to competitors - MSN

Jul 14, 2026

Is Medtronic PLC (MDT) a Bargain After 5.1% Drop? GF Value Says Undervalued - GuruFocus

Jul 14, 2026

Medtronic recalls heart valve delivery catheter for risk of tip detaching - MedTech Dive

Jul 14, 2026

FDA Flags Medtronic Harmony Catheter Recall As Class I Over Tip Detachment - insights.citeline.com

Jul 14, 2026

Baird Adjusts Price Target on Medtronic to $91 From $85, Maintains Neutral Rating - marketscreener.com

Jul 14, 2026

Jul 13, 2026

BTIG Research Adjusts Medtronic Price Target to $91 From $90, Maintains Buy Rating - marketscreener.com

Jul 13, 2026

Comprehensive Nerve Repair Biomaterials Market Report Published, Profiles Medtronic, Stryker, Boston Scientific, and 20 Other Key Players - Yahoo Finance

Jul 13, 2026